BEHAVIORAL MEDICINE

行为医学

基本信息

项目摘要

Six protocols are currently active and conducted out of the Consultation- Liaison Service-based behavioral medicine research program. These protocols examine the phenomenology and biological correlates of illness or treatment-induced mood, behavioral, and cognitive changes. The protocols address such areas as: a) the effects of previous psychiatric history on the psychiatric morbidity associated with certain diseases and their treatment; b) the psychiatric phenomenology of certain diseases and their treatment; c) the treatment response characteristics of psychiatric disorders associated with medical diseases or their treatment; d) biochemical factors that may serve as predictive diagnostic markers for illness or for treatment-associated mood/behavioral or cognitive syndromes; e) the effects of mood state alterations on immunologic function. Significant findings to date include demonstration of the following: 1) significant reduction in thyroid and reproductive axis activity during anabolic steroid administration; 2) significant increase in IL-2 and discoordination of IL-1 and IL-2 secretion by anabolic steroids; 3) evidence of significant cognitive impairment and negative affective symptoms in association with blunted endocrine response to anabolic steroids, with significant positive affective symptoms associated with more robust hormonal responses to anabolic steroids; 4) preliminary evidence of the antidepressant efficacy of thyroid hormone (T4) in patients with central hypothyroidism.
目前有六项议定书是在协商框架内执行的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

D R RUBINOW其他文献

D R RUBINOW的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('D R RUBINOW', 18)}}的其他基金

HORMONAL STUDIES OF AFFECTIVE DISORDER
情感障碍的荷尔蒙研究
  • 批准号:
    3968413
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
BEHAVIORAL MEDICINE
行为医学
  • 批准号:
    3968414
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PSYCHOBIOLOGY AND TREATMENT OF MENSTRUALLY-RELATED MOOD DISORDERS
心理生物学和月经相关情绪障碍的治疗
  • 批准号:
    3921854
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
HORMONAL STUDIES OF AFFECTIVE DISORDERS
情感障碍的荷尔蒙研究
  • 批准号:
    3759348
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PSYCHOBIOLOGY AND TREATMENT OF MENSTRUALLY-RELATED MOOD DISORDERS
心理生物学和月经相关情绪障碍的治疗
  • 批准号:
    3759347
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PSYCHOBIOLOGY AND TREATMENT OF PERI-MENOPAUSAL MOOD DISORDERS
围绝经期情绪障碍的心理生物学和治疗
  • 批准号:
    3759465
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
PSYCHOBIOLOGY AND TREATMENT OF MENSTRUALLY-RELATED MOOD DISORDERS
心理生物学和月经相关情绪障碍的治疗
  • 批准号:
    5203645
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
HORMONAL STUDIES OF AFFECTIVE DISORDER
情感障碍的荷尔蒙研究
  • 批准号:
    3921855
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
HORMONAL STUDIES OF AFFECTIVE DISORDERS
情感障碍的荷尔蒙研究
  • 批准号:
    5202749
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
HORMONAL STUDIES OF AFFECTIVE DISORDER
情感障碍的荷尔蒙研究
  • 批准号:
    3944618
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

Stratification of depression based on lysophospholipid metabolic disorders and innovative development of novel antidepressants
基于溶血磷脂代谢紊乱的抑郁症分层及新型抗抑郁药的创新开发
  • 批准号:
    23H02839
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The role of antidepressants in central and peripheral myeloid HIV persistence and inflammation
抗抑郁药在中枢和外周髓系 HIV 持续存在和炎症中的作用
  • 批准号:
    10762810
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
  • 批准号:
    10679095
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Concomitant use of antidepressants and oral antidiabetic drugs and the risk of hypoglycemia
抗抑郁药和口服抗糖尿病药的同时使用和低血糖的风险
  • 批准号:
    10526807
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
Leveraging Rapid-Acting Antidepressants for Personalized Response
利用速效抗抑郁药进行个性化治疗
  • 批准号:
    10387133
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Leveraging Rapid-Acting Antidepressants for Personalized Response
利用速效抗抑郁药进行个性化治疗
  • 批准号:
    10490846
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Leveraging Rapid-Acting Antidepressants for Personalized Response
利用速效抗抑郁药进行个性化反应
  • 批准号:
    10687872
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
  • 批准号:
    10569044
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
Do antidepressants promote the wound healing of the diabetes?
抗抑郁药能促进糖尿病伤口愈合吗?
  • 批准号:
    20K09860
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Relapse risk after Discontinuation of Antidepressants during Pregnancy (R-DAP study)
怀孕期间停用抗抑郁药后复发的风险(R-DAP 研究)
  • 批准号:
    10117285
  • 财政年份:
    2020
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了